Viewing nowHyunephecil Tablet 5 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 5.215mg
Tablet · Prescription medication
Hyuons Meditech Co., Ltd.

MFDS item code 202002109 · Approved 2020.03.26 · Insurance code 670402280
Treatment of symptoms of Alzheimer-type dementia
This medication is used to treat symptoms of Alzheimer's type dementia, helping with memory decline, improvement of cognitive function, and enhancement of daily living abilities. This treatment contributes to slowing the progression of the patient's symptoms and improving the quality of daily life. It primarily focuses on maintaining or improving cognitive function and is also effective in preventing symptom deterioration. This medication treats dementia symptoms caused by Alzheimer's disease.
○ Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. When this medicine is discontinued, its effects gradually decline, and no rebound effect occurs following abrupt discontinuation. ○ Female patients aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg daily.
○ Children: There is no experience with use in children.
This medication contains donepezil hydrochloride as its active ingredient and is used for the treatment of Alzheimer's type dementia symptoms. This medication should not be administered to certain patients. For example, those with allergies to this medication or its components, pregnant women or those who may become pregnant, breastfeeding women, and patients with genetic lactose intolerance should not use this medication. In patients with heart disease or a history of peptic ulcers, asthma or obstructive pulmonary disease, and patients with extrapyramidal disorders such as Parkinson's disease, this medication should be used with caution, as it may affect heart rate or exacerbate gastrointestinal symptoms. During treatment with this medication, various adverse reactions may occur. Reports have indicated issues such as heart problems, gastrointestinal bleeding, liver dysfunction, cerebrovascular disorders, motor dysfunction, severe muscle problems, difficulty breathing, acute pancreatitis, acute kidney failure, and sudden death, among others. Common side effects may include nausea, vomiting, diarrhea, dizziness, insomnia, hallucinations, anxiety, headaches, and fatigue. This medication is approved only for patients with Alzheimer's type dementia and should not be used for other types of dementia or memory decline. Treatment should be carried out under the supervision of an experienced physician, and discontinuation should be considered if there is no therapeutic effect. Due to the risk of increasing heart arrhythmias, patients with heart disease or a history of QT interval prolongation may require regular electrocardiograms. Additionally, caution should be exercised with patients taking anti-inflammatory pain relievers to reduce the risk of gastrointestinal bleeding. This medication may affect driving or machinery operation, so caution is necessary during initial doses or dose changes. This medication may interact with other drugs; special caution is warranted when used with drugs that affect the CYP3A4 and CYP2D6 enzymes. Some muscle relaxants or anticholinergic medications may also interact with this medication. Women who are pregnant or breastfeeding should not use this medication, and if necessary, they should consult a specialist. Safety in pediatrics has not been established, so it should not be used in children. In cases of overdose, serious symptoms such as vomiting, bradycardia, seizures, and respiratory suppression may occur, and immediate medical attention is necessary. Atropine may be used as an antidote. This medication should be kept out of the reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air or moisture access. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and safety.
Yellow spherical film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 5.215mg
Tablet · Prescription medication
Hyuons Meditech Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.